OraSure Technologies, Inc. Commences Initial Studies For FDA Approval Of Home Use Rapid HIV Test Kit

BETHLEHEM, Pa.--(BUSINESS WIRE)--OraSure Technologies, Inc. (NASDAQ: OSUR), the market leader in oral fluid diagnostics and the manufacturer of the OraQuick ADVANCE® Rapid HIV-1/2 Antibody Test, announced today that it has commenced several laboratory-based operational studies as the initial stage of the process to obtain U.S. Food and Drug Administration (“FDA”) approval of the OraQuick ADVANCE® test for use in the consumer or over-the-counter (“OTC”) market in the United States.